Department of Ultrasound Diagnosis, Peking University Third Hospital, Beijing, China.
Department of Ultrasound Diagnosis, Peking University Third Hospital, Beijing, China.
Ultrasound Med Biol. 2021 Apr;47(4):960-966. doi: 10.1016/j.ultrasmedbio.2020.12.005. Epub 2021 Jan 15.
The Breast Imaging Reporting and Data System (BI-RADS) standards have limitations regarding classifying and managing central intra-ductal papillary masses. Changes to the standards are necessary to provide early and effective treatment. To summarize the ultrasonographic imaging features of central mammary ductal papillary masses, this retrospective study included 56 participants. In identifying benign versus malignant lesions, the most significant indicators were angular edges and the long diameter of the tumor parallel to the duct. In the comparison of diagnostic efficacy for central mammary ductal tumors, the post-operative pathologic malignant upgrade rate of BI-RADS was 33.3%, and that of the new standard criteria was 14.2%. The angle of the wall of the tumor relative to the duct was most helpful. When BI-RADS is used to evaluate a papillary mass in a central duct, it is more accurate when the tumor is parallel to the duct than parallel to the skin.
乳腺影像报告和数据系统 (BI-RADS) 标准在对中央导管内乳头状肿块进行分类和管理方面存在局限性。为了提供早期和有效的治疗,有必要对标准进行修改。为了总结中央乳腺导管乳头状肿块的超声影像学特征,本回顾性研究纳入了 56 名参与者。在鉴别良性与恶性病变时,最有意义的指标是边缘角度和肿瘤长径与导管平行。在比较中央乳腺导管肿瘤的诊断效能时,BI-RADS 的术后病理恶性升级率为 33.3%,新标准的为 14.2%。肿瘤相对于导管的壁角最有帮助。当 BI-RADS 用于评估中央导管内的乳头状肿块时,当肿瘤与导管平行时比与皮肤平行时更准确。